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Abstract
Background: Aeromonas species, particularly Aeromonas hydrophila, cause a wide spectrum of diseases in human
being such as gastroenteritis; soft tissue infections including necrotizing fasciitis, meningitis, peritonitis, and
bacteremia; but pneumonia and respiratory tract infections are uncommon.
Methods: Case report and literature review.
Results: A 30-year-old victim of a motor vehicle crash sustained pelvic fractures and splenic injury. Delayed
splenic rupture caused sudden cardiorespiratory arrest. The patient was resuscitated but suffered septic shock
and severe hypoxemia refractory to advanced mechanical ventilatory strategies. Aeromonas hydrophila was iso-
lated as the causative pathogen of severe bilateral pneumonia. Venovenous extracorporeal membrane oxy-
genation (ECMO) was used temporarily. The patient recovered uneventfully.
Conclusion: This is the first case, to our knowledge, of the use of ECMO in a trauma patient with severe
fulminant A. hydrophila pneumonia. Clinicians should be aware of the characteristics of this pathogen and
associated clinical infections.
Aeromonas species are water-borne motile gram-negative non-spore-forming bacilli widely distributed
in the aquatic environment, both fresh- and salt-water. The
species has been implicated in rare opportunistic infections in
humans involved in aquatic trauma, those with burns, and
immunocompromised patients such as those with leukemia
or other cancer [1].
Aeromonas species, particularly Aeromonas hydrophila, cause
awide spectrum of diseases in humans such as gastroenteritis,
soft tissue infections including necrotizing fasciitis, meningi-
tis, peritonitis, and bacteremia [2–9]. Although there are re-
ports of extraintestinal human infections caused byAeromonas
in both immunocompromised and immunocompetent pa-
tients, respiratory tract infections remain uncommon [10–12].
To our knowledge, the present paper is the first report of the
use of extracorporeal membrane oxygenation (ECMO) sup-
port for severe acute respiratory distress syndrome (ARDS)
related to Aeromonas pneumonia.
We report a patient involved in a motor vehicle crash who
sustained multiple injuries and developed severe pneumonia
with worsening hypoxemia and ARDS requiring ECMO.
Aeromonas hydrophila was the causative pathogen.
Case Report
A 30-year-old otherwise-healthy man was involved in a
rollover motor vehicle crash as an unrestrained driver with
ejection from the vehicle onto the pavement. The patient was
neurologically and hemodynamically stable on the scene. He
was airlifted to the University of Michigan Medical Level I
Trauma Center. The initial examination confirmed hemody-
namic stability, and the injuries included multiple pelvic
fractures and a grade I splenic injury with no free fluid in the
peritoneum by computed tomography (CT) imaging of the
abdomen/pelvis. No thoracic injuries were identified by chest
radiography (Fig. 1). He was admitted for non-operative
management of his pelvic fractures and splenic injury.
On post-injury day 3, he was found in cardiac arrest with
pulselss electrical activity. The Advanced Cardiac Life Sup-
port protocol was initiated, with endotracheal intubation
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and resuscitation, leading to return of spontaneous cardiac
rhythm and blood pressure, and he was transferred to the
intensive care unit. He was intubated on first attempt, Mal-
lampati Class I laryngoscopy view, with no evidence of as-
piration. Delayed splenic rupture was confirmed by CT scan
of the abdomen performed immediately after stabilization of
hemodynamics (Fig. 2). Angiographic embolization was
successful.
The patient subsequently developed severe hypoxemia
with increasing oxygen requirement, and bilateral infiltrates
were noted on the chest radiograph consistent with ARDS or
bilateral bacterial or aspiration pneumonia (Fig. 3). A CT scan
confirmed no evidence of pulmonary embolus. Evidence of
hepatic ischemic injury with increased serum concentrations
of his liver enzymes was noted on laboratory examination.
Persistent fever and neutropenia developed, with a decrease
in the white blood cell count to a nadir of 1.0109/dL. At this
time, he had evidence of septic shock with multiple organ
dysfunction syndrome, including acute renal failure necessi-
tating renal replacement therapy. Cultures of blood and urine
were obtained, and diagnostic bronchoscopy with bronch-
oalveolar lavage and quantitative cultures were performed
to evaluate for pneumonia as a sepsis source. Empiric
antimicrobial management with intravenous piperacillin-
tazobactam and vancomycin was initiated. Vasopressors
(norepinephrine, vasopressin) and steroids were used
for management of his septic shock. Granulocyte colony-
stimulating factor (G-CSF) was given as treatment for severe
neutropenia.
The patient’s respiratory function continued to deteriorate,
with persistent hypoxemia despite the provision of high FiO2
(1.0). Multiple mechanical ventilation strategies were used in
attempts to improve oxygenation, including recruitment
maneuvers, inverse-ratio pressure control ventilation, and
high-frequency oscillatory ventilation (HFOV), but hypox-
emia persisted.
An ECMO evaluation was requested for severe ARDS and
refractory hypoxemia, and, given the likely reversible nature
of his pulmonary disease and hypoxemia, he was cannulated
for venovenous ECMO (VV-ECMO) with right internal jug-
ular and right femoral cannulas. Full systemic anticoagulation
with continuous infusion of unfractionated heparin was ini-
tiated for ECMO. Because he had undergone angiographic
embolization of his splenic injury two days prior, it was rec-
ognized that he was at high risk for intra-abdominal bleeding,
which would be difficult to diagnose. A diagnostic peritoneal
lavage (DPL) catheter was inserted (open technique) after
initiation of VV-ECMO tomonitor for signs of intra-peritoneal
bleeding while on ECMO and maintained sterile with an oc-
clusive dressing. The catheter was interrogated daily by sterile
saline lavage.
FIG 1. Chest radiograph on hospital admission post-accident revealing no traumatic injuries. Normal chest radiograph.
FIG. 2. Computed tomography scan of abdomen doc-
umenting splenic rupture, hemoperitoneum, and angio-
graphic coil embolization.
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Cultures of bronchoalveolar lavage fluid confirmed Aero-
monas hydrophila > 10,000 colony-forming units (CFU)/mL
and Streptococcus pneumoniae > 10,000 CFU/mL (Table 1). All
other cultures, including of blood, were negative. Levo-
floxacin was added, and the dose for piperacillin-tazobactam
was adjusted according to the minimum inhibitory concen-
tration (MIC) values on the microbiology report.
In anticipation of a prolonged need for ventilatory support,
open tracheostomy was performed on VV-ECMO day two.
The white blood cell count normalized, and G-CSF was dis-
continued. Hepatic enzymes normalized gradually. He was
removed from ECMO after lung recruitment with HFOV. The
ECMO was discontinued, and he was decannulated on
postinjury day nine (VV-ECMO duration six days). An infe-
rior vena cava (IVC) filter was placed just prior to decannu-
lation with intravascular ultrasound guidance at the bedside
in the surgical intensive care unit, with confirmation of IVC
thrombus during the procedure. He was transitioned from
HFOV to conventional ventilatory support with bilevel ven-
tilation. He had full renal recovery, and renal replacement
therapy was discontinued. Liberation from mechanical ven-
tilation occurred on postinjury day 27, and his tracheostomy
tube was removed (Fig. 4). The patient had a full uneventful
recovery thereafter and was discharged home on postinjury
day 51, able to perform all activities of daily living and with
no neurologic sequelae from the cardiac arrest and severe
hypoxemia.
Discussion
Aeromonas species is a rare causative agent of human in-
fection. It is associated with high mortality rates, as high as
70% [13]. Aeromonas hydrophila is the most common species
implicated in human infections, with rare reports of A. caviae
and A. sobria causing infections of burn patients, also with
high mortality [14]. Aeromonas hydrophila, a member of the
family Vibrionaceae, is a gram-negative bacillus, a catalase-
and oxidase-positive, facultative anaerobe that is ubiquitous;
it is common in aquatic media and has a worldwide distri-
bution. It is isolated frequently from water, soil, and certain
FIG. 3. Chest radiograph after cannulation for venovenous extracorporeal membrane oxygenation demonstrating bilateral
infiltrates consistent with acute respiratory distress syndrome or bilateral pneumonia.
Table 1. Antimicrobial Susceptibilities (Minimum
Inhibitory Concentrations) of Pathogens Identified
in Bronchoalveolar Lavage Fluid Cultures
Aeromonas
hydrophila
>10,000 CFU/mL
Streptococcus
pneumoniae
>10,000 CFU/mL
Penicillin <0.06
Cefepime <8.00
Piperacillin <8.00
Piperacillin-
tazobactam
<8/4
Cefuroxime <0.25
Cefoxitin <8.00
Ceftriaxone <8.00 <0.06
Aztreonam <1.00
Meropenem <4.00 <0.03
Gentamicin <4.00
Tobramycin <4.00
Amikacin <16.00
Trimethoprim-
sulfamethoxazole
<2/38 .12/2.37
Erythromycin <0.06
Clindamycin <0.06
Doxycycline <4.00 <0.50
Vancomycin <0.125
Levofloxacin <2.00 <0.50
Ciprofloxacin <1.00
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foods. In immunocompetent hosts, respiratory infection at-
tributable to this pathogen occurs by ingestion of contami-
nated water [15].
Aeromonas hydrophila is generally susceptible to a wide
range of antimicrobial drugs [16]. Aeromonas species can ex-
press b-lactamases and hence may be resistant to penicillin,
first-generation cephalosporins, vancomycin, and clinda-
mycin [17]. Despite the abundant knowledge about inducible,
chromosomally-mediated b-lactamases among Aeromonas
species, extended-spectrum beta-lactamase (ESBL)-producing
A. hydrophila strains have rarely been isolated in clinical
practice [18]. There are recent reports of A. hydrophila strains
resistant to tetracyclines, cotrimoxazole, aminoglycosides,
and extended-spectrum cephalosporins [19–21]. Apart from
rare reports in the literature [22,23], A. hydrophila is consis-
tently sensitive to third-generation cephalosporins, aztreo-
nam, fluoroquinolones, aminoglycosides, and carbapenems
[24–26].
Risk factors for Aeromonas infection include an immuno-
compromised state and an environmental water or soil source
[27,28]. The gastrointestinal tract is the main portal of entry.
Soft tissue infections, including necrotizing infections, have
been reported in instances of injury and contamination of
open wounds with soil [29,30]. Additional reports of sepsis in
burn patients have documented contact with soil or water.
However, severe, even fatal, Aeromonas infections have
been reported in immunocompetent normal children with
pneumonia and sepsis [31,32]. Aeromonas also has been re-
ported as a causative pathogen in cases of near-drowning-
associated pneumonia [33].
The portal of entry of the Aeromonas organism was not
readily identified in our patient, although aspiration may have
occurred after ejection. Presumed aspiration pneumonia caused
byAeromonas hydrophila in immunocompetent patients has been
described previously [34]. We also investigated the possibility
that the patient acquired the infection through the hospital en-
vironment, either via the ventilator or as a cross-infection while
in the trauma/burn ICU, but therewere no reports of additional
Aeromonas clinical infections in that ICU for the time period.
The severity of theA. hydrophila pneumonia infection in this
patient necessitated the use of VV-ECMO as a bridging
strategy to pulmonary recovery. The ECMO required full
systemic anticoagulation with heparin, and, given the pa-
tient’s underlying splenic injury, we utilized a DPL catheter as
an inexpensive, reliable, and readily available monitoring
device for signs of intraperitoneal bleeding, because transport
of ECMO patients to a CT scanner can be challenging. This
case highlights the potentially serious nature of Aeromonas
pneumonia infection in trauma patients.
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